Best evidence in critical care medicine: The use of recombinant human erythropoietin to reduce red cell transfusions in critically ill patients
Osama Almuslim, David LeasaVolume:
51
Language:
english
Pages:
2
DOI:
10.1007/bf03018406
Date:
June, 2004
File:
PDF, 35 KB
english, 2004